Symetis
Ecublens, Vaud, Switzerland
About Symetis
Symetis is a Swiss Company developing innovative minimally invasive heart valve replacement therapies for patients suffering from heart valve diseases. Symetis is dedicated to improving patient care and safety by offering simple, accurate solutions for heart valve replacement. Its proprietary Acurate™Aortic Valve Replacement System features a unique self-positioning design providing facile implant positioning and alignment as well as unrivalled ease of use.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $56.7M
- Funding stage: M&A
- Last round: Series D (May 2012)
- Website: bostonscientific.com
- Phone: +41216510160
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/symetis-2499246 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.